- Article
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
- Cristina Müller,
- Josefine Reber,
- Stephanie Haller,
- Holger Dorrer,
- Ulli Köster,
- Karl Johnston,
- Konstantin Zhernosekov,
- Andreas Türler and
- Roger Schibli
Terbium-149 is among the most interesting therapeutic nuclides for medical applications. It decays by emission of short-range α-particles (Eα = 3.967 MeV) with a half-life of 4.12 h. The goal of this study was to investigate the anticancer efficacy...

